Global OTC Dry Eye Drops Market Growth 2024-2030
This report studies OTC dry eyedrop market. OTC eyedrops refer to eyedrops dispensed without a prescription. Over-the-counter eye drops offer a convenient assortment for various eye health needs.
The global OTC Dry Eye Drops market size is projected to grow from US$ 2531 million in 2024 to US$ 3135 million in 2030; it is expected to grow at a CAGR of 3.6% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “OTC Dry Eye Drops Industry Forecast” looks at past sales and reviews total world OTC Dry Eye Drops sales in 2023, providing a comprehensive analysis by region and market sector of projected OTC Dry Eye Drops sales for 2024 through 2030. With OTC Dry Eye Drops sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC Dry Eye Drops industry.
This Insight Report provides a comprehensive analysis of the global OTC Dry Eye Drops landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on OTC Dry Eye Drops portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OTC Dry Eye Drops market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC Dry Eye Drops and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC Dry Eye Drops.
United States market for OTC Dry Eye Drops is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for OTC Dry Eye Drops is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for OTC Dry Eye Drops is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key OTC Dry Eye Drops players cover Alcon, Bausch Health, AbbVie, Santen Pharma, CooperVision, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Dry Eye Drops market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Sodium Hyaluronate Eye Drops
Sodium Carboxymethylcellulose Eye Drops
Other
Segmentation by Application:
Teenagers
Middle Age
Older Adult
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alcon
Bausch Health
AbbVie
Santen Pharma
CooperVision
Thea pharmaceuticals
URSAPHARM
OmniVision Pharma
Rohto
Prestige Consumer Healthcare
LION
Kenvue (VISINE)
Zhenshiming
Key Questions Addressed in this Report
What is the 10-year outlook for the global OTC Dry Eye Drops market?
What factors are driving OTC Dry Eye Drops market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do OTC Dry Eye Drops market opportunities vary by end market size?
How does OTC Dry Eye Drops break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.